Skip to main content
. 2022 Oct 1;8:403. doi: 10.1038/s41420-022-01119-w

Fig. 2. OTUD1 attenuates the resistance of NSCLC cells to erlotinib.

Fig. 2

A OTUD1 expression in PC-9/ER and PC-9 cells determined by RT-qPCR. B Transduction efficiency of oe-OTUD1 in PC-9/ER cells and sh-OTUD1 in PC-9 cells determined by RT-qPCR. C IC50 value of erlotinib in oe-OTUD1-treated PC-9/ER cells and sh-OTUD1-treated PC-9 cells determined by CCK-8 assay. D Clonogenic potential of oe-OTUD1-treated PC-9/ER cells and sh-OTUD1-treated PC-9 cells determined by colony formation assay. E Apoptosis rate of oe-OTUD1-treated PC-9/ER cells and sh-OTUD1-treated PC-9 cells measured by flow cytometry. *p < 0.05, **p < 0.01, ***p < 0.001. Data are shown as mean ± standard deviation of three technical replicates. Data between two groups were compared by unpaired t test.